Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery

References

• Mainardes RM, Silva LP. Drug delivery systems: past, present, and future. Curr Drug Targets. 2004 Jul;5(5):449–455.
   PubMed Web of Science ®Google Scholar
• Robinson DH, Mauger JW. Drug delivery systems. Am J Health-Syst Pharm. 1991;48(10_suppl):S14–S23.
   Web of Science ®Google Scholar
• Zang X, Lee JB, Deshpande K, et al. Prevention of paclitaxel-induced neuropathy by formulation approach. J Control Release. 2019 Jun;10(303):109–116.
   Web of Science ®Google Scholar
• Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Adv Drug Deliv Rev. 2019 Apr;144:57–77.
   PubMed Web of Science ®Google Scholar
• Jain V, Jain S, Mahajan SC. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment. Curr Drug Deliv. 2015;12(2):177–191.
   PubMed Web of Science ®Google Scholar
• Lombardo D, Kiselev MA, Caccamo MT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. 2019;2019:1–26.
   Web of Science ®Google Scholar
• Tran S, DeGiovanni PJ, Piel B, et al. Cancer nanomedicine: a review of recent success in drug delivery. Clin Transl Med. 2017 Dec 11;6(1):44.
   PubMed Web of Science ®Google Scholar
• Taratula O, Garbuzenko OB, Chen AM, et al. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J Drug Target. 2011 Dec;19(10):900–914.
   PubMed Web of Science ®Google Scholar
• Taratula O, Garbuzenko O, Savla R, et al. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr Drug Deliv. 2011 Jan;8(1):59–69.
   PubMed Web of Science ®Google Scholar
• Chen AM, Taratula O, Wei D, et al. Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles “out” of DNA/siRNA complexes. ACS Nano. 2010 Jul 27;4(7):3679–3688.
   PubMed Web of Science ®Google Scholar
• Zylberberg C, Matosevic S. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug Deliv. 2016 Nov;23(9):3319–3329.
   PubMed Web of Science ®Google Scholar
• Minko T, Pakunlu RI, Wang Y, et al. New generation of liposomal drugs for cancer. Anticancer Agents Med Chem. 2006 Nov;6(6):537–552.
   PubMedGoogle Scholar
• Mendes LP, Sarisozen C, Luther E, et al. Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers. Drug Deliv. 2019 Dec;26(1):443–458.
   PubMed Web of Science ®Google Scholar
• Almousallam M, Moia C, Zhu H. Development of nanostructured lipid carrier for dacarbazine delivery. Int Nano Lett. 2015;5(4):241–248.
   Web of Science ®Google Scholar
• Gomes MJ, Martins S, Ferreira D, et al. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine. 2014;9:1231–1242.
   PubMed Web of Science ®Google Scholar
• Taratula O, Garbuzenko OB, Kirkpatrick P, et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release. 2009 Dec 16;140(3):284–293.
   PubMed Web of Science ®Google Scholar
• Taratula O, Kuzmov A, Shah M, et al. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release. 2013 Nov 10;171(3):349–357.
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB, Winkler J, Tomassone MS, et al. Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs. Langmuir. 2014 Nov 4;30(43):12941–12949.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li H, Lee RJ. Targeted drug delivery via folate receptors. Expert Opin Drug Deliv. 2008 Mar;5(3):309–319.
   PubMed Web of Science ®Google Scholar
• Alley SC, Okeley NM, Senter PD. Antibody-drug conjugates: targeted drug delivery for cancer. Curr Opin Chem Biol. 2010 Aug;14(4):529–537.
   PubMed Web of Science ®Google Scholar
• Alibakhshi A, Kahaki AF, Ahangarzadeh S, et al. Targeted cancer therapy through antibody fragments-decorated nanomedicines. J Control Release. 2017 Dec;28(268):323–334.
   Web of Science ®Google Scholar
• Chu DT, Bac ND, Nguyen KH, et al. An update on Anti-CD137 antibodies in immunotherapies for cancer. Int J Mol Sci. 2019 Apr 12;20(8):1822.
   Web of Science ®Google Scholar
• Chandna P, Saad M, Wang Y, et al. Targeted proapoptotic anticancer drug delivery system. Mol Pharm. 2007 Sep-Oct;4(5):668–678.
   PubMed Web of Science ®Google Scholar
• Dharap SS, Qiu B, Williams GC, et al. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release. 2003 Aug 28;91(1–2):61–73.
   PubMed Web of Science ®Google Scholar
• Dharap SS, Wang Y, Chandna P, et al. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12962–12967.
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB, Kuzmov A, Taratula O, et al., Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy. Theranostics. 2019;9(26): 8362–8376.
   PubMed Web of Science ®Google Scholar
• Saad M, Garbuzenko OB, Ber E, et al. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? J Control Release. 2008 Sep 10;130(2):107–114.
   PubMed Web of Science ®Google Scholar
• Savla R, Garbuzenko OB, Chen S, et al. Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy. Pharm Res. 2014 Dec;31(12):3487–3502.
   PubMed Web of Science ®Google Scholar
• Li X, Taratula O, Taratula O, et al. LHRH-targeted drug delivery systems for cancer therapy. Mini Rev Med Chem. 2017;17(3):258–267.
   PubMed Web of Science ®Google Scholar
• Onaca O, Enea R, Hughes DW, et al. Stimuli-responsive polymersomes as nanocarriers for drug and gene delivery. Macromol Biosci. 2009 Feb 11;9(2):129–139.
   PubMed Web of Science ®Google Scholar
• Rao NV, Ko H, Lee J, et al. Recent progress and advances in stimuli-responsive polymers for cancer therapy. Front Bioeng Biotechnol. 2018;6:110.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Akimoto J, Okano T. Polymeric micelles with stimuli-triggering systems for advanced cancer drug targeting. J Drug Target. 2014 Aug;22(7):584–599.
   PubMed Web of Science ®Google Scholar
• Hu YW, Du YZ, Liu N, et al. Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier. J Control Release. 2015 May;28(206):91–100.
   Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013 Nov;12(11):991–1003.
   PubMed Web of Science ®Google Scholar
• Alvarez-Lorenzo C, Garcia-Gonzalez CA, Bucio E, et al. Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release. Expert Opin Drug Deliv. 2016 Aug;13(8):1109–1119.
   PubMed Web of Science ®Google Scholar
• Do HD, Couillaud BM, Doan BT, et al. Advances on non-invasive physically triggered nucleic acid delivery from nanocarriers. Adv Drug Deliv Rev. 2019 1;Jan(138):3–17.
   Web of Science ®Google Scholar
• Fouladi F, Steffen KJ, Mallik S. Enzyme-responsive liposomes for the delivery of anticancer drugs. Bioconjug Chem. 2017 Apr 19;28(4):857–868.
   PubMed Web of Science ®Google Scholar
• Ganta S, Devalapally H, Shahiwala A, et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 2008 Mar 20;126(3):187–204.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H. Recent advances in endogenous and exogenous stimuli-responsive nanocarriers for drug delivery and therapeutics. Chem Pharm Bull (Tokyo). 2017;65(7):612–617.
   PubMed Web of Science ®Google Scholar
• Li Y, Xiao K, Zhu W, et al. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Adv Drug Deliv Rev. 2014 Feb;66:58–73.
   PubMed Web of Science ®Google Scholar
• Tayo LL. Stimuli-responsive nanocarriers for intracellular delivery. Biophys Rev. 2017 Dec;9(6):931–940.
   PubMedGoogle Scholar
• Raza A, Rasheed T, Nabeel F, et al. Endogenous and exogenous stimuli-responsive drug delivery systems for programmed site-specific release. Molecules. 2019 Mar 21;24:6.
   Web of Science ®Google Scholar
• Lokina S, Stephen A, Kaviyarasan V, et al. Cytotoxicity and antimicrobial activities of green synthesized silver nanoparticles. Eur J Med Chem. 2014 Apr;9(76):256–263.
   Web of Science ®Google Scholar
• Wolfbeis OS. An overview of nanoparticles commonly used in fluorescent bioimaging. Chem Soc Rev. 2015 Jul 21;44(14):4743–4768.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185–198.
   PubMed Web of Science ®Google Scholar
• Khandare JJ, Chandna P, Wang Y, et al. Novel polymeric prodrug with multivalent components for cancer therapy. J Pharmacol Exp Ther. 2006 Jun;317(3):929–937.
   PubMed Web of Science ®Google Scholar
• Shen S, Wu Y, Liu Y, et al. High drug-loading nanomedicines: progress, current status, and prospects. Int J Nanomedicine. 2017;12:4085–4109.
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009 Jun;86(3):215–223.
   PubMed Web of Science ®Google Scholar
• Nie S, Xing Y, Kim GJ, et al. Nanotechnology applications in cancer. Annu Rev Biomed Eng. 2007;9:257–288.
   PubMed Web of Science ®Google Scholar
• Sawant RR, Torchilin VP. Multifunctional nanocarriers and intracellular drug delivery. Curr Opin Solid State Mater Sci. 2012;16(6):269–275.
   Web of Science ®Google Scholar
• Gao X, Cui Y, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol. 2004 Aug;22(8):969–976.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee JE, Lee SH, et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer- targeted imaging and magnetically guided drug delivery. Adv Mater. 2008;20(3):478–483.
   Web of Science ®Google Scholar
• Yang J, Lee CH, Ko HJ, et al. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew Chem Int Ed Engl. 2007;46(46):8836–8839.
   PubMed Web of Science ®Google Scholar
• Liong M, Lu J, Kovochich M, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano. 2008 May;2(5):889–896.
   PubMed Web of Science ®Google Scholar
• Guo Y, Shi D, Cho H, et al. In vivo imaging and drug storage by quantum-dot-conjugated carbon nanotubes. Adv Funct Mater. 2008;18(17):2489–2497.
   Web of Science ®Google Scholar
• Li JL, Day D, Gu M. Ultra-low energy threshold for cancer photothermal therapy using transferrin-conjugated gold nanorods. Adv Mater. 2008;20(20):3866–3871.
   Web of Science ®Google Scholar
• Trapani G, Denora N, Trapani A, et al. Recent advances in ligand targeted therapy. J Drug Target. 2012 Jan;20(1):1–22.
   PubMed Web of Science ®Google Scholar
• Bhaskar S, Tian F, Stoeger T, et al. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol. 2010;7(3).
   Web of Science ®Google Scholar
• Chandna P, Khandare JJ, Ber E, et al. Multifunctional tumor-targeted polymer-peptide-drug delivery system for treatment of primary and metastatic cancers. Pharm Res. 2010 Nov;27(11):2296–2306.
   PubMed Web of Science ®Google Scholar
• Zhang M, Garbuzenko OB, Reuhl KR, et al. Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases. Nanomedicine (Lond). 2012 Feb;7(2):185–197.
   PubMed Web of Science ®Google Scholar
• Chen AM, Zhang M, Wei D, et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small. 2009 Dec;5(23):2673–2677.
   PubMed Web of Science ®Google Scholar
• Jaimes-Aguirre L, Gibbens-Bandala BV, Morales-Avila E, et al. Polymer-based drug delivery systems, development and pre-clinical status. Curr Pharm Des. 2016;22(19):2886–2903.
   PubMed Web of Science ®Google Scholar
• Mendes LP, Pan J, Torchilin VP. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules. 2017 Aug 23;22:9.
   Web of Science ®Google Scholar
• Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007 Jan;24(1):1–16.
   PubMed Web of Science ®Google Scholar
• Sutradhar KB, Amin ML. Nanoemulsions: increasing possibilities in drug delivery. Eur J Nanomed. 2013;5(2):97–110.
   Google Scholar
• Wang Z, Qiao R, Tang N, et al. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer. Biomaterials. 2017 May;127:25–35.
   PubMed Web of Science ®Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975–999.
   PubMed Web of Science ®Google Scholar
• Mohan A, Narayanan S, Sethuraman S, et al. Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma. Biomed Res Int. 2014;2014:424239.
   PubMed Web of Science ®Google Scholar
• Kotla NG, Chandrasekar B, Rooney P, et al. Biomimetic lipid-based nanosystems for enhanced dermal delivery of drugs and bioactive agents. ACS Biomater Sci Eng. 2017;3(7):1262–1272.
   PubMed Web of Science ®Google Scholar
• Sercombe L, Veerati T, Moheimani F, et al. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.
   PubMed Web of Science ®Google Scholar
• Lamichhane N, Udayakumar TS, D’Souza WD, et al. Liposomes: clinical applications and potential for image-guided drug delivery. Molecules. 2018 Jan 30;23(2):288.
   PubMed Web of Science ®Google Scholar
• Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine. 2013 Sep;8(9):1509–1528.
   PubMed Web of Science ®Google Scholar
• Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine. 2012;7:49–60.
   PubMed Web of Science ®Google Scholar
• Bulbake U, Doppalapudi S, Kommineni N, et al. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017 Mar 27;9:2.
   Web of Science ®Google Scholar
• Bobo D, Robinson KJ, Islam J, et al. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res. 2016 Oct;33(10):2373–2387.
   PubMed Web of Science ®Google Scholar
• Li SD, Chono S, Huang L. Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. J Control Release. 2008 Feb 18;126(1):77–84.
   PubMed Web of Science ®Google Scholar
• Betigeri S, Zhang M, Garbuzenko O, et al. Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage. Drug Deliv Transl Res. 2011 Feb;1(1):13–24.
   PubMed Web of Science ®Google Scholar
• Pakunlu RI, Wang Y, Tsao W, et al. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system. Cancer Res. 2004 Sep 1;64(17):6214–6224.
   PubMed Web of Science ®Google Scholar
• Wang Y, Saad M, Pakunlu RI, et al. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor. Clin Cancer Res. 2008 Jun 1;14(11):3607–3616.
   PubMed Web of Science ®Google Scholar
• Peddada LY, Garbuzenko OB, Devore DI, et al. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes. J Control Release. 2014 Nov;28(194):103–112.
   Web of Science ®Google Scholar
• Kang MH, Yoo HJ, Kwon YH, et al. Design of multifunctional liposomal nanocarriers for folate receptor-specific intracellular drug delivery. Mol Pharm. 2015 Dec 7;12(12):4200–4213.
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB, Saad M, Pozharov VP, et al. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10737–10742.
   PubMed Web of Science ®Google Scholar
• Shah V, Taratula O, Garbuzenko OB, et al. Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids. Curr Drug Discov Technol. 2013 Mar;10(1):8–15.
   PubMedGoogle Scholar
• Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine. 2007;2(3):289–300.
   PubMed Web of Science ®Google Scholar
• Khosa A, Reddi S, Saha RN. Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother. 2018 Jul;103:598–613.
   PubMed Web of Science ®Google Scholar
• Battaglia L, Serpe L, Foglietta F, et al. Application of lipid nanoparticles to ocular drug delivery. Expert Opin Drug Deliv. 2016 Dec;13(12):1743–1757.
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB, Kbah N, Kuzmov A, et al. Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers. J Control Release. 2019 Feb;28(296):225–231.
   Web of Science ®Google Scholar
• Kuzmov A, Minko T. Nanotechnology approaches for inhalation treatment of lung diseases. J Control Release. 2015 Dec;10(219):500–518.
   Web of Science ®Google Scholar
• Emami J, Rezazadeh M, Sadeghi H, et al. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design. Pharm Dev Technol. 2017 May;22(3):370–382.
   PubMed Web of Science ®Google Scholar
• Jiang S, Eltoukhy AA, Love KT, et al. Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery. Nano Lett. 2013 Mar 13;13(3):1059–1064.
   PubMed Web of Science ®Google Scholar
• Marcu A, Pop S, Dumitrache F, et al. Magnetic iron oxide nanoparticles as drug delivery system in breast cancer. Appl Surf Sci. 2013;281:60–65.
   Web of Science ®Google Scholar
• Stephen ZR, Dayringer CJ, Lim JJ, et al. Approach to rapid synthesis and functionalization of iron oxide nanoparticles for high gene transfection. ACS Appl Mater Interfaces. 2016 Mar;8(10):6320–6328.
   PubMed Web of Science ®Google Scholar
• Jin L, Wang Q, Chen J, et al. Efficient delivery of therapeutic siRNA by Fe3O4 magnetic nanoparticles into oral cancer cells. Pharmaceutics. 2019 Nov 17;11(11):615.
   Web of Science ®Google Scholar
• Wang YX, Idee JM. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg. 2017 Feb;7(1):88–122.
   PubMed Web of Science ®Google Scholar
• Cheng W, Nie J, Xu L, et al. pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS Appl Mater Interfaces. 2017 Jun 7;9(22):18462–18473.
   PubMed Web of Science ®Google Scholar
• Hom C, Lu J, Liong M, et al. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small. 2010 6;6;Jun(11):1185–1190.
   Web of Science ®Google Scholar
• Yang Y, Wan J, Niu Y, et al. Structure-dependent and glutathione-responsive biodegradable dendritic mesoporous organosilica nanoparticles for safe protein delivery. Chem Mater. 2016;28(24):9008–9016.
   Web of Science ®Google Scholar
• Ray H, Baughman AAZ, de Heer WA. Carbon nanotubes—the route toward applications. Science. 2002;297:787–792.
   PubMed Web of Science ®Google Scholar
• Wu W, Wieckowski S, Pastorin G, et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl. 2005 Oct 7;44(39):6358–6362.
   PubMed Web of Science ®Google Scholar
• Feazell RP, N-R N, Dai H, et al. Soluble single-walled carbon nanotubes as longboat delivery systems for Platinum(IV) anticancer drug design. J Am Chem Soc. 2007;129:8438–8439.
   PubMed Web of Science ®Google Scholar
• Dhar S, Liu Z, Thomale J, et al. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc. 2008;130:11467–11476.
   PubMed Web of Science ®Google Scholar
• Hilder TA, Hill JM. Probability of encapsulation of paclitaxel and doxorubicin into carbon nanotubes. Micro Nano Lett. 2008;3:2.
   Web of Science ®Google Scholar
• Pantarotto D, Singh R, McCarthy D, et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed Engl. 2004 Oct 4;43(39):5242–5246.
   PubMed Web of Science ®Google Scholar
• Ravi Singh DP, McCarthy D, Chaloin O, et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc. 2005;127:4388–4396.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008 Aug 15;68(16):6652–6660.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Blais MO, Harris GM, et al. PLGA-carbon nanotube conjugates for intercellular delivery of caspase-3 into osteosarcoma cells. PLoS One. 2013;8(12):e81947.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Jain NK. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery. Mol Pharm. 2015 Feb 2;12(2):630–643.
   PubMed Web of Science ®Google Scholar
• Valizadeh A, Mikaeili H, Samiei M, et al. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 2012;7(480):1–14.
   PubMed Web of Science ®Google Scholar
• Ozkan M. Quantum dots and other nanoparticles: what can they offer to drug discovery? Drug Discov Today. 2004;9(24):1065–1071.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang Z, Zong S, et al. A graphene quantum dot-based FRET system for nuclear-targeted and real-time monitoring of drug delivery. Nanoscale. 2015 Oct 7;7(37):15477–15486.
   PubMed Web of Science ®Google Scholar
• Olerile LD, Liu Y, Zhang B, et al. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic. Colloids Surf B Biointerfaces. 2017 Feb;1(150):121–130.
   Web of Science ®Google Scholar
• Mahajan SD, Roy I, Xu G, et al. Enhancing the delivery of anti retroviral drug “Saquinavir” across the blood brain barrier using nanoparticles. Curr HIV Res. 2010;8(5):396–404.
   PubMed Web of Science ®Google Scholar
• Savla R, Taratula O, Garbuzenko O, et al. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release. 2011 Jul 15;153(1):16–22.
   PubMed Web of Science ®Google Scholar
• An X, Zhu A, Luo H, et al. Rational design of multi-stimuli-responsive nanoparticles for precise cancer therapy. ACS Nano. 2016 Jun 28;10(6):5947–5958.
   PubMed Web of Science ®Google Scholar
• Castillo B, Bromberg L, Lopez X, et al. Intracellular delivery of siRNA by polycationic superparamagnetic nanoparticles. J Drug Deliv. 2012;2012:218940.
   PubMedGoogle Scholar
• Uthaman S, Huh KM, Park IK. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications. Biomater Res. 2018;22:22.
   PubMedGoogle Scholar
• Liu M, Du H, Zhang W, et al. Internal stimuli-responsive nanocarriers for drug delivery: design strategies and applications. Mater Sci Eng C Mater Biol Appl. 2017 Feb;1(71):1267–1280.
   Web of Science ®Google Scholar
• Wells J, Sen A, Hui SW. Localized delivery to CT-26 tumors in mice using thermosensitive liposomes. Int J Pharm. 2003;261(1–2):105–114.
   PubMed Web of Science ®Google Scholar
• Na K, Lee KH, Lee DH, et al. Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier. Eur J Pharm Sci. 2006 Feb;27(2–3):115–122.
   PubMed Web of Science ®Google Scholar
• Ishida T, Kirchmeier MJ, Moase EH, et al. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta. 2001;1515(2):144–158.
   PubMed Web of Science ®Google Scholar
• Lee E. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release. 2003;91(1–2):103–113.
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Amiji M. Poly(Ethylene Glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine. 2007;3:32–42.
   PubMed Web of Science ®Google Scholar
• Balakirev M, Schoehn G, Chroboczek J. Lipoic acid-derived amphiphiles for redox-controlled DNA delivery. Chem Biol. 2000;7:813–819.
   PubMed Web of Science ®Google Scholar
• Yang Y, Aw J, Chen K, et al. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging. Chem Asian J. 2011 6;6; Jun(6): 1381–1389.
   Web of Science ®Google Scholar
• Baier G, Cavallaro A, Vasilev K, et al. Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection. Biomacromolecules. 2013 Apr 8;14(4):1103–1112.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kate P, Torchilin VP. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. ACS Nano. 2012 Apr 24;6(4):3491–3498.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao M, Cao N, et al. Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment. Biomater Sci. 2020 Mar 31;8(7):1885–1896.
   PubMed Web of Science ®Google Scholar
• Nikravan G, Haddadi-Asl V, Salami-Kalajahi M. Stimuli-responsive DOX release behavior of cross-linked poly(acrylic acid) nanoparticles. e-Polymers. 2019;19:203–214.
   Web of Science ®Google Scholar
• Cook JA, Pass HI, lype SN, et al. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res. 1991;51:4287–4294.
   PubMed Web of Science ®Google Scholar
• Cho H, Bae J, Garripelli VK, et al. Redox-sensitive polymeric nanoparticles for drug delivery. Chem Commun (Camb). 2012 Jun 18;48(48):6043–6045.
   PubMed Web of Science ®Google Scholar
• Ong W, Yang Y, Cruciano AC, et al. Redox-triggered contents release from liposomes. J Am Chem Soc. 2008;130:14739–14744.
   PubMed Web of Science ®Google Scholar
• Ryu J-H, Chacko RT, Jiwpanich S, et al. Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform. J Am Chem Soc. 2010;132:17227–17235.
   PubMed Web of Science ®Google Scholar
• Yang HY, Jang MS, Li Y, et al. Multifunctional and redox-responsive self-assembled magnetic nanovectors for protein delivery and dual-modal imaging. ACS Appl Mater Interfaces. 2017 Jun 7;9(22):19184–19192.
   PubMed Web of Science ®Google Scholar
• Harris TJ, von Maltzahn G, Lord ME, et al. Protease-triggered unveiling of bioactive nanoparticles. Small. 2008 Sep;4(9):1307–1312.
   PubMed Web of Science ®Google Scholar
• Terada T, Iwai M, Kawakami S, et al. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting. J Control Release. 2006 Apr 10;111(3):333–342.
   PubMed Web of Science ®Google Scholar
• Banerjee J, Hanson AJ, Gadam B, et al. Release of liposomal contents by cell-secreted matrix metalloproteinase-9. Bioconjug Chem. 2009 Jul;20(7):1332–1339.
   PubMed Web of Science ®Google Scholar
• Singh N, Karambelkar A, Gu L, et al. Bioresponsive mesoporous silica nanoparticles for triggered drug release. J Am Chem Soc. 2011 Dec 14;133(49):19582–19585.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Akita H, Ito E, et al. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid. Biomaterials. 2011 Jun;32(18):4306–4316.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu C, Wen L, et al. A hyaluronidase-responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Res. 2016 Dec 15;76(24):7208–7218.
   PubMed Web of Science ®Google Scholar
• Rodbard D, Moore MJ, Rodbard D. The role of regional body temperature in the pathogenesis of disease. N Engl J Med. 1981;305:808–814.
   PubMed Web of Science ®Google Scholar
• Lee SH, Choi SH, Kim SH, et al. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release. 2008 Jan 4;125(1):25–32.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen H, Xu L, et al. The targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model. J Control Release. 2008;131(1):34–40.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Hao J, Lee LA, et al. Thermally controlled release of anticancer drug from self-assembled gamma-substituted amphiphilic poly(epsilon-caprolactone) micellar nanoparticles. Biomacromolecules. 2012 Jul 9;13(7):2163–2173.
   PubMed Web of Science ®Google Scholar
• Chen K-J, Liang H-F, Chen H-L, et al. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery. ACS Nano. 2013;7(1):438–446.
   PubMed Web of Science ®Google Scholar
• Rapoport NY, Kennedy AM, Shea JE, et al. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release. 2009 Sep 15;138(3):268–276.
   PubMed Web of Science ®Google Scholar
• Wang CH, Kang ST, Lee YH, et al. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials. 2012 Feb;33(6):1939–1947.
   PubMed Web of Science ®Google Scholar
• Schroeder A, Honen R, Turjeman K, et al. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J Control Release. 2009 Jul 1;137(1):63–68.
   PubMed Web of Science ®Google Scholar
• Kheirolomoom A, Mahakian LM, Lai C-Y, et al. Copper−doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Mol Pharm. 2010;7:1948–1958.
   PubMed Web of Science ®Google Scholar
• Sirsi SR, Borden MA. State-of-the-art materials for ultrasound-triggered drug delivery. Adv Drug Deliv Rev. 2014 Jun;72:3–14.
   PubMed Web of Science ®Google Scholar
• Gao ZG, Fain HD, Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release. 2005 Jan 20;102(1):203–222.
   PubMed Web of Science ®Google Scholar
• Jung SH, Na K, Lee SA, et al. Gd(III)-DOTA-modified sonosensitive liposomes for ultrasound-triggered release and MR imaging. Nanoscale Res Lett. 2012;7:462.
   PubMed Web of Science ®Google Scholar
• Juan L, Vivero-Escoto IIS, Wu C-W, et al. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc. 2009;131:3462–3463.
   PubMed Web of Science ®Google Scholar
• Liu YC, Le Ny AL, Schmidt J, et al. Photo-assisted gene delivery using light-responsive catanionic vesicles. Langmuir. 2009 May 19;25(10):5713–5724.
   PubMed Web of Science ®Google Scholar
• Tong R, Hemmati HD, Langer R, et al. Photoswitchable nanoparticles for triggered tissue penetration and drug delivery. J Am Chem Soc. 2012 May 30;134(21):8848–8855.
   PubMed Web of Science ®Google Scholar
• He D, He X, Wang K, et al. A light-responsive reversible molecule-gated system using thymine-modified mesoporous silica nanoparticles. Langmuir. 2012 Feb 28;28(8):4003–4008.
   PubMed Web of Science ®Google Scholar
• Agasti SS, Chompoosor A, You CC, et al. Photoregulated release of caged anticancer drugs from gold nanoparticles. J Am Chem Soc. 2009 Apr 29;131(16):5728–5729.
   PubMed Web of Science ®Google Scholar
• Lu J, Choi E, Tamanoi F, et al. Light-activated nanoimpeller-controlled drug release in cancer cells. Small. 2008 4; Apr(4): 421–426.
   Web of Science ®Google Scholar
• Yuan Q, Zhang Y, Chen T, et al. Photon-manipulated drug release from a mesoporous nanocontainer controlled by azobenzene-modified nucleic acid. ACS Nano. 2012 Jul 24;6(7):6337–6344.
   PubMed Web of Science ®Google Scholar
• Li N, Yu Z, Pan W, et al. A near-infrared light-triggered nanocarrier with reversible DNA valves for intracellular controlled release. Adv Funct Mater. 2013;23(18):2255–2262.
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Wang YA, Li XL, Mo YZ, et al. Effects of tumor metabolic microenvironment on regulatory T cells. Mol Cancer. 2018 Nov 26;17(1):168.
   PubMed Web of Science ®Google Scholar
• Spill F, Reynolds DS, Kamm RD, et al. Impact of the physical microenvironment on tumor progression and metastasis. Curr Opin Biotechnol. 2016 Aug;40:41–48.
   PubMed Web of Science ®Google Scholar
• Alfarouk KO, Muddathir AK, Shayoub ME. Tumor acidity as evolutionary spite. Cancers (Basel). 2011 Jan 20;3(1):408–414.
   PubMedGoogle Scholar
• Korneev KV, Atretkhany KN, Drutskaya MS, et al. TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis. Cytokine. 2017 Jan;89:127–135.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zheng C, Wang L, et al. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging. Acta Biomater. 2017 Oct;15(62):293–305.
   Web of Science ®Google Scholar
• Shi X, Ma X, Hou M, et al. pH-Responsive unimolecular micelles based on amphiphilic star-like copolymers with high drug loading for effective drug delivery and cellular imaging. J Mater Chem B. 2017 Sep 7;5(33):6847–6859.
   PubMed Web of Science ®Google Scholar
• Lin W, Yao N, Qian L, et al. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. Acta Biomater. 2017 Aug;58:455–465.
   PubMed Web of Science ®Google Scholar
• Chen Q, Feng L, Liu J, et al. Intelligent Albumin-MnO2 nanoparticles as pH-/H2 O2 -responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy. Adv Mater. 2016 Sep;28(33):7129–7136.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang R, Liang C, et al. Manganese dioxide coated WS2 @Fe3 O4/sSiO2 nanocomposites for pH-responsive MR imaging and oxygen-elevated synergetic therapy. Small. 2018;14:2.
   Web of Science ®Google Scholar
• Li J, Liu F, Shao Q, et al. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells. Adv Healthc Mater. 2014 Aug;3(8):1230–1239.
   PubMed Web of Science ®Google Scholar
• Hu Q, Katti PS, Gu Z. Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale. 2014 Nov 7;6(21):12273–12286.
   PubMed Web of Science ®Google Scholar
• de la Rica R, Aili D, Stevens MM. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv Drug Deliv Rev. 2012 Aug;64(11):967–978.
   PubMed Web of Science ®Google Scholar
• Kanapathipillai M, Brock A, Ingber DE. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv Drug Deliv Rev. 2014 Dec;15;79-80:107–118.
   Web of Science ®Google Scholar
• Huang WC, Chen SH, Chiang WH, et al. Tumor microenvironment-responsive nanoparticle delivery of chemotherapy for enhanced selective cellular uptake and transportation within tumor. Biomacromolecules. 2016 Dec 12;17(12):3883–3892.
   PubMed Web of Science ®Google Scholar
• Peng J, Yang Q, Xiao Y, et al. Tumor microenvironment responsive drug‐dye‐peptide nanoassembly for enhanced tumor‐targeting, penetration, and photo‐chemo‐immunotherapy. Adv Funct Mater. 2019;29:19.
   Web of Science ®Google Scholar
• Du J, Lane LA, Nie S. Stimuli-responsive nanoparticles for targeting the tumor microenvironment. J Control Release. 2015 Dec;10(219):205–214.
   Web of Science ®Google Scholar
• Fernandes C, Suares D, Yergeri MC. Tumor microenvironment targeted nanotherapy. Front Pharmacol. 2018;9:1230.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ju Y, Ali Z, et al. Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics. Nat Commun. 2019 Sep 27;10(1):4418.
   PubMed Web of Science ®Google Scholar
• Yang HY, Jang MS, Li Y, et al. Hierarchical tumor acidity-responsive self-assembled magnetic nanotheranostics for bimodal bioimaging and photodynamic therapy. J Control Release. 2019 May;10(301):157–165.
   Web of Science ®Google Scholar
• Cheng R, Meng F, Deng C, et al. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials. 2013 May;34(14):3647–3657.
   PubMed Web of Science ®Google Scholar
• Curcio A, Marotta R, Riedinger A, et al. Magnetic pH-responsive nanogels as multifunctional delivery tools for small interfering RNA (siRNA) molecules and iron oxide nanoparticles (IONPs). Chem Commun. 2012;48:2400–2402.
   PubMed Web of Science ®Google Scholar
• Hathout RM, Metwally AA, El-Ahmady SH, et al. Dual stimuli-responsive polypyrrole nanoparticles for anticancer therapy. J Drug Deliv Sci Tec. 2018;47:176–180.
   Web of Science ®Google Scholar
• Jia X, Zhang Y, Zou Y, et al. Dual intratumoral redox/enzyme-responsive NO-releasing nanomedicine for the specific, high-efficacy, and low-toxic cancer therapy. Adv Mater. 2018 Jul;30(30):e1704490.
   PubMed Web of Science ®Google Scholar
• Gan Q, Lu X, Yuan Y, et al. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica. Biomaterials. 2011 Mar;32(7):1932–1942.
   PubMed Web of Science ®Google Scholar
• Menon JU, Kuriakose A, Iyer R, et al. Dual-drug containing core-shell nanoparticles for lung cancer therapy. Sci Rep. 2017 Oct 16;7(1):13249.
   PubMed Web of Science ®Google Scholar
• Lee Y, Lee S, Lee DY, et al. Multistimuli-responsive Bilirubin nanoparticles for anticancer therapy. Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10676–10680.
   PubMed Web of Science ®Google Scholar
• Xiong D, Zhang X, Peng S, et al. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging. Colloids Surf B Biointerfaces. 2018 Mar;1(163):29–40.
   Web of Science ®Google Scholar
• Yang HY, Jang M-S, Gao GH, et al. Construction of redox/pH dual stimuli-responsive PEGylated polymeric micelles for intracellular doxorubicin delivery in liver cancer. Polym Chem. 2016;7(9):1813–1825.
   Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018 Sep 19;16(1):71.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Doxil(R)–the first FDA-approved nano-drug: lessons learned. J Control Release. 2012 Jun 10;160(2):117–134.
   PubMed Web of Science ®Google Scholar
• Ta T, Porter TM. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release. 2013 Jul 10;169(1–2):112–125.
   PubMed Web of Science ®Google Scholar
• Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. P&T. 2017;42:742–755.
   PubMedGoogle Scholar
• Hua S, de Matos MBC, Metselaar JM, et al. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization [review]. Front Pharmacol. 2018 [2018 Jul 17];9(790). doi:10.3389/fphar.2018.00790.
   Web of Science ®Google Scholar
• Schmutz M, Borges O, Jesus S, et al. A methodological safe-by-design approach for the development of nanomedicines [perspective]. Front Bioeng Biotechnol. 2020 [2020 Apr 02];8(258). doi:10.3389/fbioe.2020.00258.
   Web of Science ®Google Scholar
• Marques C, Som C, Schmutz M, et al. How the lack of Chitosan characterization precludes implementation of the safe-by-design concept [review]. Front Bioeng Biotechnol. 2020 [2020 Mar 10];8(165). doi:10.3389/fbioe.2020.00165.
   Web of Science ®Google Scholar
• Mauri E, Perale G, Rossi F. Nanogel Functionalization: A versatile approach to meet the challenges of drug and gene delivery.ACS Appl Nano Mater. 2018 [2018 12 28];1(12):6525–6541.
   Web of Science ®Google Scholar
• Pinelli F, Sacchetti A, Perale G, et al. Is nanoparticle functionalization a versatile approach to meet the challenges of drug and gene delivery? Ther Deliv. 2020;11(7):401–404.
   PubMed Web of Science ®Google Scholar
• Schwarz-Plaschg C, Kallhoff A, Eisenberger I. Making nanomaterials safer by design?NanoEthics. 2017 [2017 12 01];11(3):277–281.
   Web of Science ®Google Scholar
• De Jong WH, B PJA. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3:133–149.
   PubMed Web of Science ®Google Scholar
• Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008 Jan;4(1):26–49.
   PubMed Web of Science ®Google Scholar
• Pourmand A, Abdollahi M. Current opinion on nanotoxicology. DARU J Pharma Sci. 2012;20(1):95–97.
   Web of Science ®Google Scholar
• Dreher KL. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicol Sci. 2004 Jan;77(1):3–5.
   PubMed Web of Science ®Google Scholar
• Hagens WI, Oomen AG, de Jong WH, et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol. 2007 Dec;49(3):217–229.
   PubMed Web of Science ®Google Scholar
• Nemmar A, Hoet PHM, Vanquickenborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002;105:411–414.
   PubMed Web of Science ®Google Scholar
• Garnett MC, Kallinteri P. Nanomedicines and nanotoxicology: some physiological principles. Occup Med (Lond). 2006 Aug;56(5):307–311.
   PubMed Web of Science ®Google Scholar
• Yang L, Watts DJ. Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicol Lett. 2005 Aug 14;158(2):122–132.
   PubMed Web of Science ®Google Scholar
• Patel P, Shah J. Safety and toxicological considerations of nanomedicines: the future directions. Curr Clin Pharmacol. 2017;12(2):73–82.
   PubMed Web of Science ®Google Scholar